Cargando…
IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284885/ https://www.ncbi.nlm.nih.gov/pubmed/35841010 http://dx.doi.org/10.1186/s13287-022-02982-1 |
_version_ | 1784747662421000192 |
---|---|
author | Qin, Hong Sun, Chenglu Zhu, Yanglin Qin, Yafei Ren, Shaohua Wang, Zhaobo Li, Chuan Li, Xiang Zhang, Baoren Hao, Jingpeng Li, Guangming Wang, Hongda Shao, Bo Zhang, Jingyi Wang, Hao |
author_facet | Qin, Hong Sun, Chenglu Zhu, Yanglin Qin, Yafei Ren, Shaohua Wang, Zhaobo Li, Chuan Li, Xiang Zhang, Baoren Hao, Jingpeng Li, Guangming Wang, Hongda Shao, Bo Zhang, Jingyi Wang, Hao |
author_sort | Qin, Hong |
collection | PubMed |
description | BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression can enhance the therapeutic effects of ERCs in inhibition of acute cardiac allograft rejection remains unknown and will be explored in this study. METHODS: C57BL/6 mice recipients receiving BALB/c mouse heterotopic heart allografts were randomly divided into the phosphate-buffered saline (untreated), ERC treated, negative lentiviral control ERC (NC-ERC) treated, and IL-37 overexpressing ERC (IL-37-ERC) treated groups. Graft pathological changes were assessed by H&E staining. The intra-graft cell infiltration and splenic immune cell populations were analyzed by immunohistochemistry and flow cytometry, respectively. The stimulatory property of recipient DCs was tested by an MLR assay. Furthermore, serum cytokine profiles of recipients were measured by ELISA assay. RESULTS: Mice treated with IL-37-ERCs achieved significantly prolonged allograft survival compared with the ERC-treated group. Compared with all the other control groups, IL-37-ERC-treated group showed mitigated inflammatory response, a significant increase in tolerogenic dendritic cells (Tol-DCs), regulatory T cells (Tregs) in the grafts and spleens, while a reduction of Th1 and Th17 cell population. Additionally, there was a significant upregulation of immunoregulatory IL-10, while a reduction of IFN-γ, IL-17A, IL-12 was detected in the sera of IL-37-ERC-treated recipients. CONCLUSION: IL-37 overexpression can promote the therapeutic effects of ERCs to inhibit acute allograft rejection and further prolong graft survival. This study suggests that gene-modified ERCs overexpressing IL-37 may pave the way for novel therapeutic options in the field of transplantation. |
format | Online Article Text |
id | pubmed-9284885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92848852022-07-16 IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection Qin, Hong Sun, Chenglu Zhu, Yanglin Qin, Yafei Ren, Shaohua Wang, Zhaobo Li, Chuan Li, Xiang Zhang, Baoren Hao, Jingpeng Li, Guangming Wang, Hongda Shao, Bo Zhang, Jingyi Wang, Hao Stem Cell Res Ther Research BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression can enhance the therapeutic effects of ERCs in inhibition of acute cardiac allograft rejection remains unknown and will be explored in this study. METHODS: C57BL/6 mice recipients receiving BALB/c mouse heterotopic heart allografts were randomly divided into the phosphate-buffered saline (untreated), ERC treated, negative lentiviral control ERC (NC-ERC) treated, and IL-37 overexpressing ERC (IL-37-ERC) treated groups. Graft pathological changes were assessed by H&E staining. The intra-graft cell infiltration and splenic immune cell populations were analyzed by immunohistochemistry and flow cytometry, respectively. The stimulatory property of recipient DCs was tested by an MLR assay. Furthermore, serum cytokine profiles of recipients were measured by ELISA assay. RESULTS: Mice treated with IL-37-ERCs achieved significantly prolonged allograft survival compared with the ERC-treated group. Compared with all the other control groups, IL-37-ERC-treated group showed mitigated inflammatory response, a significant increase in tolerogenic dendritic cells (Tol-DCs), regulatory T cells (Tregs) in the grafts and spleens, while a reduction of Th1 and Th17 cell population. Additionally, there was a significant upregulation of immunoregulatory IL-10, while a reduction of IFN-γ, IL-17A, IL-12 was detected in the sera of IL-37-ERC-treated recipients. CONCLUSION: IL-37 overexpression can promote the therapeutic effects of ERCs to inhibit acute allograft rejection and further prolong graft survival. This study suggests that gene-modified ERCs overexpressing IL-37 may pave the way for novel therapeutic options in the field of transplantation. BioMed Central 2022-07-15 /pmc/articles/PMC9284885/ /pubmed/35841010 http://dx.doi.org/10.1186/s13287-022-02982-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Qin, Hong Sun, Chenglu Zhu, Yanglin Qin, Yafei Ren, Shaohua Wang, Zhaobo Li, Chuan Li, Xiang Zhang, Baoren Hao, Jingpeng Li, Guangming Wang, Hongda Shao, Bo Zhang, Jingyi Wang, Hao IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title | IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title_full | IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title_fullStr | IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title_full_unstemmed | IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title_short | IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
title_sort | il-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284885/ https://www.ncbi.nlm.nih.gov/pubmed/35841010 http://dx.doi.org/10.1186/s13287-022-02982-1 |
work_keys_str_mv | AT qinhong il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT sunchenglu il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT zhuyanglin il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT qinyafei il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT renshaohua il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT wangzhaobo il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT lichuan il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT lixiang il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT zhangbaoren il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT haojingpeng il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT liguangming il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT wanghongda il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT shaobo il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT zhangjingyi il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection AT wanghao il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection |